Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs

Autor: Michael H Weisman, Joerg Ermann, Kristine A Kuhn, Monica Schwartzman, Sergio Schwartzman

Publikováno v: RMD Open, Vol 8, Iss 1 (2022)

Externí odkaz: https://doaj.org/article/f47a65909ea64e8ba4939d25c247c8a7

Defining the phenotype, pathogenesis and treatment of Crohn’s disease associated spondyloarthritis

Autor: Dana J. Lukin, Ellen Scherl, Monica Schwartzman, Anand Kumar, Lisa A. Mandl, Robert Battat, Randy S. Longman

Publikováno v: Journal of Gastroenterology

Peripheral and axial spondyloarthritis are the most common extra-intestinal manifestations reported in patients with Crohn’s disease. Despite the frequency of Crohn’s disease associated spondyloarthritis, clinical diagnostic tools are variably ap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7472dc68bb0506a200966efb4ea55abd
http://europepmc.org/articles/PMC7297835

Is There a Role for MRI to Establish Treatment Indications and Effectively Monitor Response in Patients with Axial Spondyloarthritis?

Autor: Walter P. Maksymowych, Monica Schwartzman

Publikováno v: Rheumatic Disease Clinics of North America. 45:341-358

MRI has an important role in the assessment of axial spondyloarthritis (axSpA), particularly early in the disease course, before radiographic damage is apparent. For this reason, MRI was incorporated into the 2009 ASAS/OMERACT classification criteria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::894ab81fa2caf75b1a6cc24f39d99700
https://doi.org/10.1016/j.rdc.2019.04.009

Who Is Ordering MRIs in Newly Diagnosed Breast Cancer Patients?

Autor: Matthew Mcmurray, Monica Schwartzman, Kathryn Friedman, Elisa R. Port, Anya Romanoff, Laurie R. Margolies, Hank Schmidt, Christina Weltz

Publikováno v: The American Surgeon. 84:351-357

The role of MRI in the workup of newly diagnosed breast cancer patients remains controversial. Breast MRI detects additional disease, but this has not translated into improved outcomes. In light of a dramatic rise in MRI use, we investigated patterns

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f29b7fa0993cee978a3cb929fa9f8039
https://doi.org/10.1177/000313481808400317

Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure

Autor: Susanne B. Nicholas, Vivette D. D'Agati, Jenny Wong, Antoine Reginensi, Helen McNeill, Kristin Meliambro, Kirk N. Campbell, John M. Basgen, Monica Schwartzman

Publikováno v: Schwartzman, M; Reginensi, A; Wong, JS; Basgen, JM; Meliambro, K; Nicholas, SB; et al.(2016). Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. Journal of the American Society of Nephrology, 27(1), 216-226. doi: 10.1681/ASN.2014090916. UCLA: Retrieved from: http://www.escholarship.org/uc/item/0dx845h7

© 2016 by the American Society of Nephrology.FSGS is the most common primary glomerular disease underlying ESRD in the United States and is increasing in incidence globally. FSGS results from podocyte injury, yet the mechanistic details of disease p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c44bd1142e409fdacdb9b44f589ce1d
https://doi.org/10.1681/asn.2014090916